Pathology of neuroendocrine neoplasms;Pathologie neuroendokriner Neoplasien

Chirurg

Volumn 82, Issue 7, 2011, Pages 567-573

  Anlauf, M ^a   Gerlach, P ^a   Schott, M ^a   Raffel, A ^a   Krausch, M ^a   Knoefel, W T ^a   Pavel, M ^b   Kloppel G ^c  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Classification; Grading; Neuroendocrine tumors; Pathology; Proliferation

Indexed keywords

TUMOR MARKER;

CANCER GRADING; CANCER STAGING; CELL PROLIFERATION; CLASSIFICATION; DIGESTIVE SYSTEM TUMOR; HUMAN; NEUROENDOCRINE TUMOR; NOMENCLATURE; PATHOLOGY; PROGNOSIS; REVIEW;

CELL PROLIFERATION; DIGESTIVE SYSTEM NEOPLASMS; HUMANS; NEOPLASM GRADING; NEOPLASM STAGING; NEUROENDOCRINE TUMORS; PROGNOSIS; TERMINOLOGY AS TOPIC; TUMOR MARKERS, BIOLOGICAL;

EID: 79959946397     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-011-2067-y     Document Type: Review

References (20)

1. Ahlman H, Nilsson O, McNicol AM et al (2008) Poorly differentiated endocrine carcinomas of midgut and hindgut origin. Neuroendocrinology 87(1): 40-46.
2. Eissele R, Anlauf M, Schäfer MKH et al (1999) Expression of vesicular monoamine transporters in endocrine hyperplasia and endocrine tumors of the oxyntic stomach. Digestion 60: 428-439.
3. Falconi M, Plockinger U, Kwekkeboom DJ et al (2006) Well-differentiated pancreatic nonfunctioning tumors/carcinoma. Neuroendocrinology 84: 196-211.
4. Heitz PU, Komminoth P, Perren A et al (2004) Pancreatic endocrine tumours: introduction. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (Hrsg) Pathology and genetics: tumours of endocrine organs. WHO classification of tumors. IARC Press, Lyon, S 177-182.
5. Klöppel G, Anlauf M (2005) Epidemiology, tumour biology and histopathological classification of neuroendocrine tumours of the gastrointestinal tract. Best Pract Res Clin Gastroenterol 19: 507-517.
6. Klöppel G, Anlauf M (2007) Gastrinoma - morphological aspects. Wien Klin Wochenschr 119: 579-584.
7. Klöppel G, Couvelard A, Perren A et al (2009) ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology 90: 162-166.
8. Klöppel G, Rindi G, Anlauf M et al (2007) Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors. Virchows Arch 451(Suppl 1): 9-27.
9. Klöppel G, Rindi G, Perren A et al (2010) The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement. Virchows Arch 456: 595-597.
10. Miederer M, Seidl S, Buck A et al (2009) Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT. Eur J Nucl Med Mol Imaging 36(1): 48-52.
11. Nilsson O, van Cutsem E, Delle Fave G et al (2006) Poorly differentiated carcinomas of the foregut (gastric, duodenal and pancreatic). Neuroendocrinology 84(3): 212-215.
12. O'Toole D, Salazar R, Falconi M et al (2006) Rare functioning pancreatic endocrine tumors. Neuroendocrinology 84(3): 189-195.
13. Pape UF, Jann H, Müller-Nordhorn J et al (2008) Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer 113(2): 256-265.
14. Rindi G, Arnold R, Bosman FT et al (2010) Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: Bosman FT, Carneiro F, Hruban RH, Theise ND (Hrsg) WHO classification of tumors of the digestive system. IARC, Lyon, S 13-14.
15. Rindi G, Klöppel G, Alhman H et al (2006) TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449: 395-401.
16. Rindi G, Klöppel G, Couvelard A et al (2007) TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 451: 757-762.
17. Schmitt AM, Riniker F, Anlauf M et al (2008) Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases. Am J Surg Pathol 32: 420-425.
18. Sobin LH, Gospodarowicz MK, Wittekind C (Hrsg) (2009) TNM classification of malignant tumours, 7. Aufl. John Wiley & Sons, New York.
19. Solcia E, Klöppel G, Sobin LH (In collaboration with 9 pathologists from 4 countries) (2000) Histological typing of endocrine tumours, 2. Aufl. WHO international histological classification of tumours. Springer, Berlin.
20. Vinik AI, Woltering EA, Warner RR et al (2010) NANETS consensus guidelines for the diagnosis of neuroendocrine tumors. Pancreas 39: 713-734.